Parkinson's Disease
PhotoBioModulation Research Institute
has been involved in the development of a New Brain Care Therapy that can slow down or reverse the progression of Parkinson's. PBMRI continues to support ongoing Clinical Studies that delivers Healing and Pain Relief through PhotoBioModulation Therapy.
"awakening" from Parkinson's Disease
Parkinson's Disease is one of several common neurodegenerative disorders. Parkinson’s Disease develops after a progressive death of many neurons in the brain. Although therapies are available to treat the signs and symptoms, the progression of neuronal death remains relentless, and it has proved difficult to slow or stop. Hence, there is a need to develop neuroprotective or disease-modifying treatments that stabilize this degeneration.
PhotoBioModulation Therapy (PBMt) Infrared Light Therapy is emerging as a safe and effective therapy that is capable of arresting neuronal death. Previous studies have used Red and Infrared Light to treat stressed tissue with much success. PBMRI proposes PBMt Infrared Light Therapy as a neuroprotective or disease-modifying treatment for Parkinson's patients.
Lower Dementia Risk than Previously thought in Parkinson's
A new study suggests that the risk of developing dementia in Parkinson’s disease patients may be lower or occur later than previously reported. Researchers analyzed data from two large studies, finding a 9% risk of dementia within 10 years for newly diagnosed patients and a 27% risk for those diagnosed for an average of six years. Factors increasing dementia risk included older age at diagnosis, being male, and lower education levels.
- 9% risk of dementia 10 years after Parkinson’s diagnosis (newly diagnosed patients).
- 27% risk of dementia 10 years after Parkinson’s diagnosis (patients diagnosed for an average of six years).
- Higher dementia risk with older age at diagnosis, being male, and lower education levels.
There is some good news for people with Parkinson’s disease: The risk of developing dementia may be lower than previously thought, or dementia may occur later in the course of the disease than previously reported, according to a study published in the August 7, 2024, online issue of Neurology.
If you have any questions regarding Parkinson's PhotoBioModulation Therapy (PBMt), contact us at https://pbmri.org/contact
Support PhotoBioModulation Research Institute
PBMRI is a 501(c)3 Charitable Non-Profit
All Donations are Tax Deductible
Your Dollars Make a Difference
